CAMBRIDGE, Mass. and TOKYO, Nov. 10 /PRNewswire/ -- Ironwood Pharmaceuticals, Inc. and Astellas Pharma Inc. today announced that they have entered into an agreement providing Astellas exclusive rights to develop and commercialize the investigational...
Full Article at RedOrbit
10 November 2009 Astellas Pharma has acquired the rights in Japan and other Asian countries to Ironwood Pharmaceuticals of the USA’s investigational irritable bowel syndrome drug linaclotide.
Full Article at PharmaTimes
Ironwood Pharmaceuticals (Ironwood ) and Astellas Pharma have entered into an agreement providing Astellas exclusive rights to develop and commercialise the investigational compound linaclotide in Japan, Indonesia, Korea, the Philippines, Taiwan, and...
Full Article at Pharmaceutical Business Review
Related Quotes
There are no results for this module. Edi the module to change the search term used to query related quotes.
We built Daylife.com using our SmartMedia Services platform, which can give you thousands of content-rich, advertiser-friendly pages (like this one) on any topic and with full editorial control. Learn More »